| GENERIC R&D Pipeline |
Pre-clinical |
Clinical Batch |
Phase I |
Registration |
Market authorization |
Launch |
| Antiacid proton-pump inhibitor
Orodispersible delayed tablet - Microgix® Patent & LCM |
|
|
|
Q2/2008 |
|
|
| Antidiabetic and hypolipidemic therapy in association
Dispersible tablet - MR dispersible tablet
LCM patented Orodispersible/Dispersible |
|
|
Q4/2008 |
|
|
|
| Antidiabetic oral therapy
Orodispersible/dispersible tablet - LCM Patent
Metformine 500mg, 850mg, 1000mg - Exclusive licence for European Territory |
|
|
|
|
|
November 2007 |
| Antihepileptic therapy
ODT/DT patent |
|
Q4/2008 |
Q2/2009 |
Q2/2008 |
|
|
| Antiviral therapy
Orodispersible/dispersible tablet - LCM |
|
|
June 2008 |
Q4/2008 |
|
|
| Antiviral therapy
XR tablet - LCM Microgix® |
|
|
June 2008 |
|
|
|
| Association of two anti-Alzheimer agents
Orodispersible tablet - LCM Patent in force |
|
|
January 2007 |
|
|
|
| Hypolipidemic therapy
MR Tablet - LCM Microgix® + Patent |
|
|
Q3/2008 |
|
|
|
